Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Grifols SA ADR stock

Learn how to easily invest in Grifols SA ADR stock.

Grifols SA ADR is a drug manufacturers-general business based in the US. Grifols SA ADR shares (GRFS) are listed on the NASDAQ and all prices are listed in US Dollars. Grifols SA ADR employs 27,584 staff and has a trailing 12-month revenue of around $5.2 billion.

How to buy shares in Grifols SA ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GRFS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Grifols SA ADR stock price (NASDAQ: GRFS)

Use our graph to track the performance of GRFS stocks over time.

Grifols SA ADR shares at a glance

Information last updated 2022-09-26.
Latest market close$6.16
52-week range$6.58 - $15.36
50-day moving average $8.75
200-day moving average $10.87
Wall St. target price$16.48
PE ratio 73.7778
Dividend yield $0 (7.09%)
Earnings per share (TTM) $0.09

Buy Grifols SA ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Grifols SA ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Grifols SA ADR price performance over time

Historical closes compared with the close of $6.16 from 2022-09-30

1 week (2022-09-26) -10.85%
1 month (2022-09-02) -19.27%
3 months (2022-07-01) -50.68%
6 months (2022-04-01) -48.37%
1 year (2021-10-01) -58.66%
2 years (2020-10-02) -63.91%
3 years (2019-10-03) 19.78
5 years (2017-10-03) 21.45

Is Grifols SA ADR stock undervalued or overvalued?

Valuing Grifols SA ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Grifols SA ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Grifols SA ADR's P/E ratio

Grifols SA ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, Grifols SA ADR shares trade at around 74x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Grifols SA ADR's PEG ratio

Grifols SA ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.196. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Grifols SA ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Grifols SA ADR's EBITDA

Grifols SA ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $698.9 million.

The EBITDA is a measure of a Grifols SA ADR's overall financial performance and is widely used to measure a its profitability.

Grifols SA ADR financials

Revenue TTM $5.2 billion
Operating margin TTM 8.87%
Gross profit TTM $2 billion
Return on assets TTM 1.55%
Return on equity TTM 1.82%
Profit margin 1.15%
Book value $4.66
Market capitalisation $5.7 billion

TTM: trailing 12 months

Grifols SA ADR share dividends

We're not expecting Grifols SA ADR to pay a dividend over the next 12 months.

Have Grifols SA ADR's shares ever split?

Grifols SA ADR's shares were split on a 2:1 basis on 3 January 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Grifols SA ADR shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Grifols SA ADR shares which in turn could have impacted Grifols SA ADR's share price.

Grifols SA ADR share price volatility

Over the last 12 months, Grifols SA ADR's shares have ranged in value from as little as $6.58 up to $15.36. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Grifols SA ADR's is 0.1902. This would suggest that Grifols SA ADR's shares are less volatile than average (for this exchange).

Grifols SA ADR overview

Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices.

Frequently asked questions

What percentage of Grifols SA ADR is owned by institutions?
Currently 42.59% of Grifols SA ADR shares are held by institutions.
How many people work for Grifols SA ADR?
Latest data suggests 27,584 work at Grifols SA ADR.
When does the fiscal year end for Grifols SA ADR?
Grifols SA ADR's fiscal year ends in December.
Where is Grifols SA ADR based?
Grifols SA ADR's address is: Avinguda de la Generalitat, 152, Barcelona, Spain, 08174
What is Grifols SA ADR's ISIN number?
Grifols SA ADR's international securities identification number is: US3984384087
What is Grifols SA ADR's CUSIP number?
Grifols SA ADR's Committee on Uniform Securities Identification Procedures number is: 398438200

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site